<DOC>
	<DOCNO>NCT00740545</DOCNO>
	<brief_summary>Standard investigation fail reveal apparent cause 50 % case recurrent spontaneous abortion . Prothrombotic mechanism initially evoke . Factor V Leiden , Prothrombin G20210A mutation protein S deficiency implicate meta-analysis Rey ( Lancet ) .However , account large number miscarriages.Gris JC coworkers ( Blood 2004 ) carry open trial , low-molecular-weight heparin versus low-dose aspirin , woman one fetal loss constitutional thrombophilic disorder . They conclude benefit action Low-molecular-weight heparin . There actually trial concern woman unexplained recurrent abortion without know thrombophilia . Nevertheless , aspirin enoxaparin often prescribe . It time assess practice . We therefore initiate multisite , double blind randomize study , enoxaparine versus placebo , woman without know thrombophilia , experience unexplained recurrent abortion .</brief_summary>
	<brief_title>Prevention Unexplained Recurrent Abortion Enoxaparine</brief_title>
	<detailed_description />
	<criteria>Women 18 45 year 2 consecutive spontaneous abortion 15th week pregnancy Unexplained abortion No maternal paternal characterize chromosomal aberration No Antiphospholipid Syndrome No anatomical abnormality possibly responsible abortion No Factor V Leiden No Prothrombin G20210A mutation No protein S deficiency No protein C deficiency No Anti thrombin 3 deficiency Proved pregnancy Contraindications enoxaparine 4000 U per day Women risk venous thromboembolism pregnancy No regular anticoagulation antiplatelet treatment Blood Hemoglobin level 10g/dl Blood platelet level 150 000/mm3 Creatinine clearance 30ml/mn Anomaly coagulation test No informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>